Biological graft showed no clear difference in awareness of prolapse (subjective failure) (16‐24 months) compared with native tissue repair (moderate certainty).
Biological graft showed no clear difference in repeat surgery for any prolapse (24 months) compared with native tissue repair (low certainty).
Biological graft showed no clear difference in recurrent posterior vaginal wall prolapse (objective failure) (16‐24… compared with native tissue repair (low certainty).
Biological graft showed no clear difference in postoperative obstructed defecation (16‐24 months) compared with native tissue repair (moderate certainty).
Biological graft showed no clear difference in postoperative dyspareunia (16‐24 months) compared with native tissue repair (low certainty).
Biological graft probably leads to higher postoperative complications (including wound infection) (16‐24 months) compared with native tissue repair (moderate certainty).
The review found no eligible studies for this question.
Transvaginal biological graft showed no clear difference in surgery for recurrent prolapse (1 to 2 years) compared with native tissue repair (moderate certainty).
Transvaginal biological graft showed no clear difference in recurrent prolapse on examination compared with native tissue repair (low certainty).
Transvaginal biological graft showed no clear difference in visceral injury compared with native tissue repair (low certainty).
It is very uncertain whether transvaginal biological graft changes bladder function compared with native tissue repair (very low certainty).
Transvaginal biological graft showed no clear difference in painful intercourse ‐ de novo dyspareunia compared with native tissue repair (moderate certainty).
It is very uncertain whether transvaginal biological graft changes quality of life compared with native tissue repair (very low certainty).
Transvaginal biological graft showed no clear difference in awareness of prolapse (1 to 3 years) compared with native tissue repair (moderate certainty).
Anterior prolapse repair: native tissue showed no clear difference in awareness of prolapse (1‐2 years) compared with biological graft (low certainty).
Anterior prolapse repair: native tissue showed no clear difference in repeat surgery for prolapse (1‐2 years) compared with biological graft (moderate certainty).
Anterior prolapse repair: native tissue probably leads to higher recurrent anterior compartment prolapse (1‐2 years) compared with biological graft (moderate certainty).
Anterior prolapse repair: native tissue showed no clear difference in stress urinary incontinence (1‐2 years) compared with biological graft (moderate certainty).
Anterior prolapse repair: native tissue showed no clear difference in dyspareunia (1‐2 years) compared with biological graft (low certainty).